184 related articles for article (PubMed ID: 34937492)
1. The race for a COVID-19 vaccine: where are we up to?
Hossain MK; Hassanzadeganroudsari M; Feehan J; Apostolopoulos V
Expert Rev Vaccines; 2022 Mar; 21(3):355-376. PubMed ID: 34937492
[TBL] [Abstract][Full Text] [Related]
2. Clinical development and approval of COVID-19 vaccines.
Kalinke U; Barouch DH; Rizzi R; Lagkadinou E; Türeci Ö; Pather S; Neels P
Expert Rev Vaccines; 2022 May; 21(5):609-619. PubMed ID: 35157542
[TBL] [Abstract][Full Text] [Related]
3. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2: vaccines in the pandemic era.
Li DD; Li QH
Mil Med Res; 2021 Jan; 8(1):1. PubMed ID: 33402220
[TBL] [Abstract][Full Text] [Related]
5. Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.
Chavda VP; Yao Q; Vora LK; Apostolopoulos V; Patel CA; Bezbaruah R; Patel AB; Chen ZS
Front Immunol; 2022; 13():961198. PubMed ID: 36263030
[TBL] [Abstract][Full Text] [Related]
6. Super-rapid race for saving lives by developing COVID-19 vaccines.
Uttarilli A; Amalakanti S; Kommoju PR; Sharma S; Goyal P; Manjunath GK; Upadhayay V; Parveen A; Tandon R; Prasad KS; Dakal TC; Ben Shlomo I; Yousef M; Neerathilingam M; Kumar A
J Integr Bioinform; 2021 Mar; 18(1):27-43. PubMed ID: 33761582
[TBL] [Abstract][Full Text] [Related]
7. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
8. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
[TBL] [Abstract][Full Text] [Related]
9. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
10. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
11. The 2020 race towards SARS-CoV-2 specific vaccines.
Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and vaccination: myths vs science.
Chavda VP; Chen Y; Dave J; Chen ZS; Chauhan SC; Yallapu MM; Uversky VN; Bezbaruah R; Patel S; Apostolopoulos V
Expert Rev Vaccines; 2022 Nov; 21(11):1603-1620. PubMed ID: 35980281
[TBL] [Abstract][Full Text] [Related]
13. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
14. Biotechnological Perspectives to Combat the COVID-19 Pandemic: Precise Diagnostics and Inevitable Vaccine Paradigms.
Aileni M; Rohela GK; Jogam P; Soujanya S; Zhang B
Cells; 2022 Mar; 11(7):. PubMed ID: 35406746
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Vaccines: Where Are We Now?
Flanagan KL; MacIntyre CR; McIntyre PB; Nelson MR
J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3535-3543. PubMed ID: 34400116
[TBL] [Abstract][Full Text] [Related]
17. Vaccination against SARS-CoV-2 and disease enhancement - knowns and unknowns.
Zellweger RM; Wartel TA; Marks F; Song M; Kim JH
Expert Rev Vaccines; 2020 Aug; 19(8):691-698. PubMed ID: 32838605
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
19. [SARS-CoV-2 vaccines].
Benfield TL; Helweg-Larsen J
Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
[TBL] [Abstract][Full Text] [Related]
20. Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.
Giordano G; Colaneri M; Di Filippo A; Blanchini F; Bolzern P; De Nicolao G; Sacchi P; Colaneri P; Bruno R
Nat Med; 2021 Jun; 27(6):993-998. PubMed ID: 33864052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
